Translations (Back To Top)

IMIC provides certified translation services of regulatory documents, study protocols,  patient–oriented materials, and Informed Consent forms.

Feasibility Studies (Back To Top)

IMIC has the capability to conduct feasibility studies to predetermine the proper study population in any therapeutic area. Therefore, IMIC has established a working relationship with governmental medical institutions to have access to their database and assess the possibility of placing trials in Mexico City or other areas of the country.

Patient Recruitment (Back To Top)

IMIC patient recruitment is a well-integrated system that has been implemented to support the patient enrollment of all IMIC studies. The system has a contact service area that tracks all calls and screened patients, and continuously feeds information to the patient database that supports recruitment for future or ongoing trials. This department is in charge of developing advertising and follow-up strategies and materials.

Regulatory Support (Back To Top)

IMIC provides support to sponsors in preparing all documents for the regulatory submission to the IRB's and the Ministry of Health agency in Mexico. This process is delegated to a specialist that deals entirely with the regulatory agency personnel.

In addition, IMIC prepares the importation of study drugs and works jointly with Mexican customs to guarantee drug availability on the initiation of all trials. We estimate that it could take approximately 60 days before the trial is initiated; from the time all study documents are received, reviewed, translated, submitted to the IRB and MoH, until the drug shipment arrives to our pharmacy.
IMIC - Flow Chart of Regulatory Approval Process

Development of Trials (Back To Top)

Clinical trials can be conducted entirely in our facility, or in hospital environments according to the study protocols, by the study team that consists of a Principal Investigator, Sub-investigators, and study coordinators. All IMIC team members are full time and trained under IMIC policies and procedures, ICH and GCP guidelines, and Mexican and FDA regulations. All trial procedures are subject to QA controls, establishing uniform high-standard operation.

Therapeutic Areas (Back To Top)

• Cardiology / Vascular Diseases

• Dental / Maxillofacial Surgery

• Dermatology

• Endocrinology including Diabetes & Obesity

• Gastroenterology including Liver Disease

• Hematology

• Immunology

• Infectious Diseases

• Musculoskeletal

• Nephrology / Urology

• Neurology / Central Nervous System

• Obstetrics / Gynecology

• Oncology

• Ophthalmology

• Otolaryngology

• Pediatrics / Neonatology

• Pharmacology / Toxicology

• Psychiatry / Anxiety and Depression

• Pulmonary / Respiratory Diseases

• Rheumatology

• Trauma

• Women's Health

IMIC - Experience Summary (Back To Top)

The following link will take you to a list of IMIC's study experiences by therapeutic areas, indication, phase of study, number of patients and our involvement.
IMIC - Study Experience Summary